Vanda Pharmaceuticals Inc (VNDA)
5.09
+0.15
(+3.04%)
USD |
NASDAQ |
Nov 22, 16:00
5.105
+0.02
(+0.29%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash from Investing (Quarterly): 12.06M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.06M |
| June 30, 2024 | -15.26M |
| March 31, 2024 | -18.22M |
| December 31, 2023 | -43.78M |
| September 30, 2023 | 35.33M |
| June 30, 2023 | -190.89M |
| March 31, 2023 | 187.29M |
| December 31, 2022 | 75.43M |
| September 30, 2022 | -21.78M |
| June 30, 2022 | -14.59M |
| March 31, 2022 | 10.87M |
| December 31, 2021 | -26.00M |
| September 30, 2021 | -16.59M |
| June 30, 2021 | -34.18M |
| March 31, 2021 | 0.071M |
| December 31, 2020 | -16.69M |
| September 30, 2020 | -47.84M |
| June 30, 2020 | 2.732M |
| March 31, 2020 | 20.30M |
| December 31, 2019 | -6.23M |
| September 30, 2019 | -13.87M |
| June 30, 2019 | -11.75M |
| March 31, 2019 | -36.45M |
| December 31, 2018 | -15.80M |
| September 30, 2018 | -8.905M |
| Date | Value |
|---|---|
| June 30, 2018 | -101.26M |
| March 31, 2018 | 16.31M |
| December 31, 2017 | 7.361M |
| September 30, 2017 | 5.404M |
| June 30, 2017 | -5.828M |
| March 31, 2017 | -17.17M |
| December 31, 2016 | 8.134M |
| September 30, 2016 | 2.368M |
| June 30, 2016 | -13.30M |
| March 31, 2016 | -7.228M |
| December 31, 2015 | 4.414M |
| September 30, 2015 | -0.279M |
| June 30, 2015 | 2.835M |
| March 31, 2015 | -33.57M |
| December 31, 2014 | -28.51M |
| September 30, 2014 | 5.715M |
| June 30, 2014 | 10.37M |
| March 31, 2014 | 0.389M |
| December 31, 2013 | -65.70M |
| September 30, 2013 | -0.007M |
| June 30, 2013 | 0.951M |
| March 31, 2013 | 30.48M |
| December 31, 2012 | -1.906M |
| September 30, 2012 | 20.29M |
| June 30, 2012 | -1.492M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-190.89M
Minimum
Jun 2023
187.29M
Maximum
Mar 2023
-5.399M
Average
-14.93M
Median
Cash from Investing (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -31.35M |
| Black Diamond Therapeutics Inc | 2.193M |
| Edgewise Therapeutics Inc | 25.36M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.58M |
| Free Cash Flow | -18.20M |
| Free Cash Flow Per Share (Quarterly) | -0.253 |
| Free Cash Flow to Equity (Quarterly) | -14.74M |
| Free Cash Flow to Firm (Quarterly) | -14.74M |
| Free Cash Flow Yield | -6.17% |